Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies

Uncategorized October 10, 2017 at 4:03 PM 0 comments

Tuebingen, Germany and Houston, Texas, USA, 04 October, 2017 – The Series E funding was supported by existing investors including dievini Hopp Biotech holding, Wellington Partners, AT Impf GmbH and others. This latest financing was also strongly supported by new life science investors and Amgen, a world-leading biotechnology company and strategic partnerRead More

Regulatory Approval in Europe Granted for Synthon’s Glatiramer Acetate 40 mg/ml

Neurology October 10, 2017 at 3:42 PM 0 comments

Nijmegen, the Netherlands, 05 October, 2017 – Synthon today announced that it has successfully concluded the decentralized procedures for glatiramer acetate 40 mg/ml pre-filled syringe for the treatment of relapsing forms of multiple sclerosis and received regulatory approval in Europe. Synthon’s three-times-a-week glatiramer acetate is a therapeutically equivalent version ofRead More

CE Marking for World’s Only Integrated HIV Self-Test from Atomo Diagnostics Gives Access to Safe, Accurate and Reliable Self-Testing

Hematology, Reproductive Health October 10, 2017 at 10:21 AM 0 comments

Atomo HIV Self Test granted CE Mark; will facilitate rollout in European and other global markets Test will be available commercially during 2018 via retail, e-commerce and public health channels Simple, safe, accurate results from a single drop of blood in minutes 3rd generation test detects HIV antibodies earlier thanRead More

Shuwen Biotech Receives CE Mark for EGFR Mutation PCR Kit for Lung Cancer

Oncology, Respiratory September 19, 2017 at 10:13 AM 0 comments

Deqing, China, 18 September, 2017 – Shuwen Biotech announced today that it has received CE-IVD marking for its EGFR real time PCR detection kit allowing the company to market its kit in countries that recognize the designation. The CE Marked kit showcases Shuwen’s strengthening research and development capabilities which ultimatelyRead More

RedHill Biopharma Initiates Promotion of Esomeprazole Strontium Delayed-Release Capsules 49.3 mg in the U.S.

Gastroenterology, Oncology September 19, 2017 at 10:11 AM 0 comments

Esomeprazole Strontium Delayed-Release (DR) Capsules 49.3 mg is an FDA-approved, proprietary, prescription proton pump inhibitor (PPI) indicated for adults for the treatment of gastroesophageal reflux disease (GERD) and other gastrointestinal (GI) conditions PPIs are one of the most commonly prescribed classes of medications in the U.S., with an estimated marketRead More

Robust Performance of OncoBEAM™ RAS CRC Liquid Biopsy Testing in Routine Clinical Practice for Colorectal Cancer Patients Highlighted at ESMO 2017

Hematology September 11, 2017 at 8:36 AM 0 comments

Hamburg, Germany, 08 September, 2017 – Sysmex Inostics, a subsidiary of Sysmex Corporation, a global leader in blood based circulating tumor DNA (ctDNA) analysis and molecular diagnostics for oncology is pleased to announce new data from a large real-world prospective evaluation of the OncoBEAM™ RAS CRC test for routine clinicalRead More

Congenica’s Sapientia™ Selected by Coimbra Paediatric Hospital for Portugal’s In2Genome Genetic Disease Diagnosis Project

Uncategorized September 6, 2017 at 10:57 AM 0 comments

Cambridge, UK, 06 September, 2017 – Congenica, a global provider of clinical genomics interpretation software, today announced a new customer partnership with the Coimbra Paediatric Hospital (CPH), a leading paediatric hospital in Portugal and part of the Coimbra Hospital and University Centre (CHUC). Through this partnership, the hospital has licensedRead More

AMAL Therapeutics Raises €8 Million (CHF 8.8 Million) in First Closing of Series B Financing Round

Uncategorized September 5, 2017 at 1:54 PM 0 comments

Financing round co-led by Boehringer Ingelheim Venture Fund, BioMedPartners and Helsinn Investment Fund Funds will be used to support: Clinical development of lead vaccine (ATP128) for colorectal cancer through to clinical proof-of-concept Further development of KISIMA technology platform for therapeutic tumour vaccination Geneva, Switzerland, 05 September, 2017 – AMAL TherapeuticsRead More

Introducing the European Medical Journal 2.3

Introducing the European Medical Journal 2.3

Uncategorized August 31, 2017 at 8:30 AM 0 comments

United Kingdom, August 31, 2017: Welcome to this year’s third instalment of the European Medical Journal. The issue contains an abundance of high-quality, peer-reviewed articles from a variety of medical fields, including oncology, cardiology, urology, and haematology. Haematologists in particular will not want to miss this edition, as it containsRead More

Philips supports global transformation of pathology with two new fully digitized labs in Austria

Uncategorized August 30, 2017 at 11:45 AM 0 comments

With availability for primary diagnostic use in North America, Europe and Asia, Philips IntelliSite Pathology Solution is helping labs worldwide to improve the efficiency and quality of cancer diagnostics. Amsterdam, 29 August, 2017 – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the continued momentum of its cutting-edgeRead More